Prenatal diagnosis for neurofibromatosis type 1 and the pitfalls of germline mosaics.
Laurence PacotDominique VidaudManuela YeAlbain ChansavangAudrey CoustierTheodora MaillardCécile BarbanceIngrid LaurendeauBérénice HébrardAriane Lunati-RozieBenoît FunalotPierre WolkensteinMichel VidaudAlice GoldenbergFanny Morice-PicardDjihad HadjadjBéatrice ParfaitÉric PasmantPublished in: NPJ genomic medicine (2024)
We report our 5-year experience in neurofibromatosis type 1 prenatal diagnosis (PND): 205 PNDs in 146 women (chorionic villus biopsies, 88% or amniocentesis, 12%). The NF1 variant was present in 85 (41%) and absent in 122 (59%) fetuses. Among 205 pregnancies (207 fetuses), 135 were carried to term (119 unaffected and 16 NF1 affected children), 69 pregnancy terminations (affected fetuses), 2 miscarriages, and 1 in utero death. The majority of PND requests came from parents with sporadic NF1. We describe two PNDs in women with mosaic NF1. In both families, direct PND showed the absence of the maternal NF1 variant in the fetus. However, microsatellite markers analysis showed that the risk haplotype had been transmitted. These rare cases of germline mosaicism illustrate the pitfall of indirect PND. Our study illustrates the crucial consequences of PND for medical and genetic counseling decisions. We also point to the challenges of germline mosaics.
Keyphrases
- signaling pathway
- lps induced
- gestational age
- pi k akt
- nuclear factor
- oxidative stress
- pregnancy outcomes
- birth weight
- preterm birth
- inflammatory response
- healthcare
- dna repair
- type diabetes
- pregnant women
- dna methylation
- polycystic ovary syndrome
- dna damage
- preterm infants
- adipose tissue
- immune response
- smoking cessation
- body mass index
- human immunodeficiency virus
- insulin resistance
- hiv testing